133 related articles for article (PubMed ID: 36348568)
1. Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
da Silva Freire AK; Furtado de Mendonça Belmont T; Pinto Santiago EJ; Cristina Cordeiro Farias I; Palmeira do Ó K; Soares da Silva A; Richardson Silva Vasconcelos L
Expert Rev Mol Diagn; 2022 Nov; 22(11):1037-1052. PubMed ID: 36348568
[TBL] [Abstract][Full Text] [Related]
2. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
Jiang Y; He J; Li Y; Guo Y; Tao H
Biomed Res Int; 2019; 2019():5179048. PubMed ID: 31871941
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
Yan SR; Liu ZJ; Yu S; Bao YX
Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
[TBL] [Abstract][Full Text] [Related]
4. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.
Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J
J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
7. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
8. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
Fang Y; Yan D; Wang L; Zhang J; He Q
J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis.
Yin H; Peng X; Ren P; Cheng B; Li S; Qin C
Tumour Biol; 2014 Dec; 35(12):12317-26. PubMed ID: 25204672
[TBL] [Abstract][Full Text] [Related]
11. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
12. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
Yang L; Wei C; Li Y; He X; He M
Biomark Med; 2020 Oct; 14(15):1485-1500. PubMed ID: 33155836
[No Abstract] [Full Text] [Related]
13. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of circulating microRNAs for hepatocellular carcinoma.
Yang Y; Zhu R
Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834
[TBL] [Abstract][Full Text] [Related]
15. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
Li G; Shen Q; Li C; Li D; Chen J; He M
Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M
Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
[No Abstract] [Full Text] [Related]
18. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
19. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinoma:a meta-analysis.
Zhang H; Ding R; Chen D
Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]